EDURANT (rilpivirine) Patient Assistance Program
Don’t let the high cost of brand HIV antiretrovirals disrupt your treatment. We help eligible patients access Edurant (rilpivirine) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Edurant (rilpivirine, RPV) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) FDA-approved as a component of antiretroviral therapy for HIV-1 infection in treatment-naïve adults and pediatric patients (≥12 years and ≥35 kg) with HIV-1 RNA ≤100,000 copies/mL at start.
- Without assistance, brand Edurant costs commonly run approximately $1,000–$1,200 per 30-day supply.
- Through AffordMyPrescriptions, qualifying patients can access Edurant for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- There is no generic rilpivirine available alone in the U.S. as of 2026. Edurant is a component of Complera, Odefsey, and Cabenuva (long-acting injectable). HIV guidelines now generally prefer integrase-inhibitor-based regimens for new starts.
What Is Edurant Prescription Assistance Program?
The Edurant Prescription Assistance Program is a manufacturer-sponsored initiative that provides Edurant at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for HIV treatment patients who are uninsured or underinsured, as well as Medicare Part D beneficiaries.
Navigating the program on your own means dealing with eligibility verification, HIV provider coordination, prior-authorization documentation, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification.
Pharmacy Price Comparison
- Without assistance, Edurant costs roughly $1,000–$1,200/month. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$1,180.00 | Save ~$1,110/mo |
| CVS Pharmacy | ~$1,200.00 | Save ~$1,130/mo |
| Walmart | ~$1,050.00 | Save ~$980/mo |
| Costco | ~$1,020.00 | Save ~$950/mo |
| Kroger | ~$1,030.00 | Save ~$960/mo |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Edurant Prescription Program?
The Patient Assistance Program is free to apply for and provides Edurant at no medication cost if approved. Our $69.95/month service covers full advocacy.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Edurant:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $1,000–$1,200 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Edurant assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Edurant Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Edurant:
Edurant (rilpivirine, RPV) is a once-daily NNRTI used as a component of combination antiretroviral therapy for HIV-1. It must be combined with at least two other antiretrovirals from different drug classes — most commonly the NRTI backbone of FTC + tenofovir.
How Edurant Works:
Rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that prevents HIV from converting its RNA genome into DNA. Unlike other inhibitors, it binds directly to the reverse transcriptase enzyme at a non-active site, distorting its shape so it can no longer function. This targeted action stops the replication process, though its effectiveness can be limited in patients with higher viral loads.
Form and use:
Marketed as Edurant, this medication is taken as a single 25 mg tablet once daily. It must be consumed with a meal of at least 533 calories to ensure proper absorption; taking it with only liquids or skipping a meal risks treatment failure. Patients must also manage timing carefully when using acid-reducing medications due to significant drug interactions.
Generic availability:
As of 2026, there is no standalone generic rilpivirine available in the United States. While it is a key component in combination therapies like Complera, Odefsey, and the injectable Cabenuva, it is no longer the primary choice for new treatments. Current HIV guidelines generally favor integrase-inhibitor-based regimens because they offer broader effectiveness and fewer interactions.
Warnings:
issues.
Edurant is not recommended for patients starting therapy with a viral load exceeding 100,000 copies/mL. Key safety concerns include depressive disorders, hepatotoxicity—particularly in those with hepatitis B or C—and potential QT prolongation at high doses. It has major drug interactions with proton pump inhibitors, which are contraindicated, as well as certain anticonvulsants and St. John’s wort.
FAQ (Frequently Asked Questions)
How Much Does Edurant Cost Without Insurance?
Edurant costs approximately $1,000–$1,200 per 30-day supply. Through AffordMyPrescriptions, qualifying patients receive Edurant at no medication cost — our $69.95 monthly fee covers full advocacy and program management
Why Does Edurant Need To Be Taken With A Meal?
Rilpivirine absorption depends on food — specifically a meal of at least 533 calories. Taking Edurant on an empty stomach or with only a snack can reduce rilpivirine levels by 50% or more, risking virologic failure and resistance. Always take Edurant with a substantial meal.
Why Aren't NNRTI Regimens Preferred Anymore?
Current HIV guidelines generally prefer integrase-inhibitor-based regimens (Biktarvy, dolutegravir-based) for new starts because integrase inhibitors have a higher barrier to resistance, fewer drug interactions, and broader effectiveness across viral loads. Rilpivirine-based regimens (Edurant + FTC/tenofovir, Complera, Odefsey, Cabenuva) are still useful — particularly in patients already suppressed and tolerating them, or those switching for tolerability — but are no longer first-line for treatment-naïve patients with high viral loads.
How Is Edurant Different From Cabenuva?
Both contain rilpivirine. Edurant is an oral once-daily tablet (rilpivirine alone, combined with other ARVs). Cabenuva is a long-acting injectable combining rilpivirine with cabotegravir, given monthly or every 2 months by a healthcare provider — eliminating daily oral pill burden for virologically suppressed adults
Can I Get Edurant Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify, especially if you face specialty-tier copays you cannot afford. State ADAP programs may also coordinate with Medicare for HIV-treatment patients
What About Drug Interactions With Acid-Reducing Medications?
Rilpivirine absorption depends on stomach acidity. Proton pump inhibitors (omeprazole, esomeprazole, etc.) are contraindicated. H2 blockers (famotidine, ranitidine) must be taken at least 12 hours before or 4 hours after Edurant. Antacids (Tums, Maalox) must be taken at least 2 hours before or 4 hours after Edurant.
What If My Application Is Denied?
If denied, we explore alternatives — switching to a different ARV regimen with its own PAP, state ADAP, the manufacturer’s copay program for commercially insured patients, or independent foundations. If we cannot find a path, you won’t be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Edurant, our team may be able to help you access assistance programs designed to make brand HIV antiretrovirals affordable. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.